DPW
CPRX icon

DiNuzzo Private Wealth’s Catalyst Pharmaceutical CPRX Stock Holding History

DiNuzzo Private Wealth’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$95 Buy
+3
New +$89 ﹤0.01% 1299
2024
Q1 		– Sell
-1
Closed -$17 – 1375
2023
Q4 		$17 Buy
+1
New +$14 ﹤0.01% 1381

Other funds holding CPRX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
LTAS
Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
OLA
Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

DiNuzzo Private Wealth's CPRX Position: Q2 2026 in Review

DiNuzzo Private Wealth opened a new position in Catalyst Pharmaceutical (CPRX) in Q2 2026: 3 shares worth $95. The stake represents ﹤0.01% of the portfolio and ranks #1299 among its holdings. This is a return to the name: DiNuzzo Private Wealth previously reported a position in CPRX as recently as Q4 2023.

DiNuzzo Private Wealth first reported a position in CPRX in Q4 2023 and has held it in 2 quarters since. 36 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • DiNuzzo Private Wealth held 3 shares of Catalyst Pharmaceutical worth $95 as of Q2 2026.
  • Catalyst Pharmaceutical was a new DiNuzzo Private Wealth position in Q2 2026.
  • Catalyst Pharmaceutical made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #1299 holding.
  • DiNuzzo Private Wealth first reported a position in Catalyst Pharmaceutical in Q4 2023 and has held it in 2 quarters since.
  • 36 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.